Bio-Path Holdings, Inc. Profile Avatar - Palmy Investing

Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P…

Biotechnology
US, Bellaire [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Bio-Path Holdings, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Bio-Path Holdings, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Bio-Path Holdings, Inc..

End of BPTH's Analysis
CIK: 1133818 CUSIP: 09057N300 ISIN: US09057N3008 LEI: - UEI: -
Secondary Listings
BPTH has no secondary listings inside our databases.